Vivo Opportunity, LLC bought INM
July 16, 2026 · Form 4 insider transaction
Vivo Opportunity, LLC bought 19 shares of InMed Pharmaceuticals Inc. at $1.55 per share, a transaction worth $29.45. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
19
Price
$1.55
Total value
$29.45
InsiderVivo Opportunity, LLC
Role—
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateJuly 16, 2026
Filing dateJuly 16, 2026
Shares owned after743,057
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., the record holder of the securities. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.